Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RO6811135 in Type 2 Diabetes
NCT01951183Phase 2Withdrawn
- Sponsor
- Roche
- Start
- Dec 2013
- Primary completion
- Dec 2013
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of sefaxersen in type 2 diabetes mellitus (T2DM), sponsored by Roche. Planned start Dec 2013; status: withdrawn.
02
Drugs
sefaxersen
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01951183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01951183.